Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger von Moos

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Onkologie|January 16, 2009
Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapyBirgit Grimm, Barbara Padberg, Thomas Ruhstaller, et al.
Onkologie|October 28, 2006
Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanomaMarc Roger Schlaeppi, Wolfgang Korte, Roger von Moos, et al.
Onkologie|December 8, 2007
Severe hyponatremia in a patient with mantle cell lymphoma treated with bortezomib: a case report and review of the literatureStefan Brodmann, Evelyne Gyr Klaas, Richard Cathomas, et al.
Onkologie|April 8, 2006
Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspectsMeritxell Garcia Alzamora, Markus Schmidli, Urs Hess, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2016
Improving quality of life in patients with advanced cancer: Targeting metastatic bone painRoger von Moos, Luis Costa, Carla Ida Ripamonti, et al.
Oncology|December 23, 2014
RANK ligand blockade with denosumab in combination with sorafenib in chemorefractory osteosarcoma: a possible step forward?Richard Cathomas, Christian Rothermundt, Beata Bode, et al.
Bone|November 10, 2021
Initiation of bone-targeted agents in patients with bone metastases and breast or castrate-resistant prostate cancer actively treated in routine clinical practice in EuropeRoger von Moos, Katie Lewis, Lucy Massey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Sarcoidosis induced by interferon-α in melanoma patients: incidence, clinical manifestations, and management strategiesLucie M Heinzerling, Mark D Anliker, Joachim Müller, et al.
Oncology Research and Treatment|November 28, 2014
Efficacy of triplet combination chemotherapy with oxaliplatin, irinotecan and capecitabine (OCX) in metastatic colorectal cancer in relation to RAS/RAF mutation status: results of a retrospective analysisStefan Brunner, Roger von Moos, Ulrich Mey, et al.
Gynecologic Oncology|August 1, 2018
Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot studyIgnace Vergote, Roger von Moos, Luis Manso, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Onkologie|January 16, 2009
Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapyBirgit Grimm, Barbara Padberg, Thomas Ruhstaller, et al.
Onkologie|October 28, 2006
Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanomaMarc Roger Schlaeppi, Wolfgang Korte, Roger von Moos, et al.
Onkologie|December 8, 2007
Severe hyponatremia in a patient with mantle cell lymphoma treated with bortezomib: a case report and review of the literatureStefan Brodmann, Evelyne Gyr Klaas, Richard Cathomas, et al.
Onkologie|April 8, 2006
Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspectsMeritxell Garcia Alzamora, Markus Schmidli, Urs Hess, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2016
Improving quality of life in patients with advanced cancer: Targeting metastatic bone painRoger von Moos, Luis Costa, Carla Ida Ripamonti, et al.
Oncology|December 23, 2014
RANK ligand blockade with denosumab in combination with sorafenib in chemorefractory osteosarcoma: a possible step forward?Richard Cathomas, Christian Rothermundt, Beata Bode, et al.
Bone|November 10, 2021
Initiation of bone-targeted agents in patients with bone metastases and breast or castrate-resistant prostate cancer actively treated in routine clinical practice in EuropeRoger von Moos, Katie Lewis, Lucy Massey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2010
Sarcoidosis induced by interferon-α in melanoma patients: incidence, clinical manifestations, and management strategiesLucie M Heinzerling, Mark D Anliker, Joachim Müller, et al.
Oncology Research and Treatment|November 28, 2014
Efficacy of triplet combination chemotherapy with oxaliplatin, irinotecan and capecitabine (OCX) in metastatic colorectal cancer in relation to RAS/RAF mutation status: results of a retrospective analysisStefan Brunner, Roger von Moos, Ulrich Mey, et al.
Gynecologic Oncology|August 1, 2018
Tumor Treating Fields in combination with paclitaxel in recurrent ovarian carcinoma: Results of the INNOVATE pilot studyIgnace Vergote, Roger von Moos, Luis Manso, et al.
Pageof 13